Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 13:43:101136.
doi: 10.1016/j.ijcha.2022.101136. eCollection 2022 Dec.

Reclassification of coronary artery disease risk using genetic risk score among subjects with borderline or intermediate clinical risk

Affiliations

Reclassification of coronary artery disease risk using genetic risk score among subjects with borderline or intermediate clinical risk

Razina A Ahmed et al. Int J Cardiol Heart Vasc. .
No abstract available

Keywords: Coronary artery disease (CAD); Reclassification; atherosclerotic cardiovascular disease (ASCVD); genetic risk score (GRS); polygenic risk score (PRS).

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Kaplan-Meier analysis for time to incident CAD from study recruitment in the UKB (White): a) four ASCVD risk groups in the entire cohort, b) with or without a family history (FH) of heart disease among subjects with borderline/intermediate-ASCVD risk, c) four GRSCAD risk groups (<0.5, 0.5–1.49, 1.5–3 and ≥ 3) among subjects with borderline/intermediate-ASCVD risk, and d) combination of FH status and GRSCAD risk groups.
Fig. 1
Fig. 1
Kaplan-Meier analysis for time to incident CAD from study recruitment in the UKB (White): a) four ASCVD risk groups in the entire cohort, b) with or without a family history (FH) of heart disease among subjects with borderline/intermediate-ASCVD risk, c) four GRSCAD risk groups (<0.5, 0.5–1.49, 1.5–3 and ≥ 3) among subjects with borderline/intermediate-ASCVD risk, and d) combination of FH status and GRSCAD risk groups.
Fig. 1
Fig. 1
Kaplan-Meier analysis for time to incident CAD from study recruitment in the UKB (White): a) four ASCVD risk groups in the entire cohort, b) with or without a family history (FH) of heart disease among subjects with borderline/intermediate-ASCVD risk, c) four GRSCAD risk groups (<0.5, 0.5–1.49, 1.5–3 and ≥ 3) among subjects with borderline/intermediate-ASCVD risk, and d) combination of FH status and GRSCAD risk groups.
Fig. 1
Fig. 1
Kaplan-Meier analysis for time to incident CAD from study recruitment in the UKB (White): a) four ASCVD risk groups in the entire cohort, b) with or without a family history (FH) of heart disease among subjects with borderline/intermediate-ASCVD risk, c) four GRSCAD risk groups (<0.5, 0.5–1.49, 1.5–3 and ≥ 3) among subjects with borderline/intermediate-ASCVD risk, and d) combination of FH status and GRSCAD risk groups.
Supplementary figure 1
Supplementary figure 1
Supplementary figure 2
Supplementary figure 2

References

    1. Wong N.D., Budoff M.J., Ferdinand K., Graham I.M., Michos E.D., Reddy T., et al. Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement. Am J Prev Cardiol. 2022;10) - PMC - PubMed
    1. Arnett D.K., Blumenthal R.S., Albert M.A., Buroker A.B., Goldberger Z.D., Hahn E.J., et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Circulation. 2019;140(11):e596–e646. - PMC - PubMed
    1. O'Sullivan J.W., Raghavan S., Marquez-Luna C., Luzum J.A., Damrauer S.M., Ashley E.A., et al. Polygenic risk scores for cardiovascular disease: A scientific statement from the american heart association. Circulation. 2022;146(8):e93–e118. - PMC - PubMed
    1. Bycroft C., Freeman C., Petkova D., Band G., Elliott L.T., Sharp K., et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562(7726):203–209. - PMC - PubMed
    1. van der Harst P., Verweij N. Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease. Circ Res. 2018;122(3):433–443. - PMC - PubMed

LinkOut - more resources